eftilagimod alpha,pembrolizumab
immutep,merck
['tacti-002', 'lcsm,(-blcsm)', '9003', 'eftilagimod', 'pembrolizumab']
#asco22 presents abs#9003 (tacti-002) investigating eftilagimod alpha (soluble lag-3 protein) and #pembrolizumab: updated results from a pd-l1 unselected population in 1st line #lcsm, encouraging results: orr 37%, dcr: 73% 
Fellow @MayoHemeOnc | @UConnIM| @UTexasSPH| @MDAndersonNews|@COVID19nCCC| #SoMeEditor @JCOCCI_ASCO| Co-Host @HemOncFellows https://t.co/dsiuV460lQ, Views my own